Nelipepimut-S Completed Phase 2 Trials for Breast Cancer Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT02297698Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
NCT01570036Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax